Tissue regeneration based on growth factor release.

Tissue engineering is an emerging biomedical field intended to assist the regeneration of body tissue defects too large to self-repair as well as to substitute for the biological functions of damaged and injured organs by using cells with proliferative and differentiative potential. In addition to basic research on such cells, it is undoubtedly indispensable for successful tissue engineering to create an artificial environment enabling cells to induce tissue regeneration. Such an environment can be achieved by making use of a scaffold for cell proliferation and differentiation and for growth factors, as well as their combination. Growth factors are often required to promote tissue regeneration, as they can induce angiogenesis, which supplies oxygen and nutrients to cells transplanted for organ substitution to maintain their biological functions. However, the biological effects of growth factors cannot always be expected because of their poor in vivo stability, unless a drug delivery system is contrived. In this article, tissue regeneration based on the release of growth factors is reviewed to emphasize the significance of drug delivery systems in tissue engineering.

[1]  S. Cook,et al.  In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.

[2]  Y. Ikada,et al.  Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. , 1998, Biomaterials.

[3]  I. Ono,et al.  A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. , 1992, Plastic and reconstructive surgery.

[4]  Y. Tabata,et al.  Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. , 2002, The Journal of thoracic and cardiovascular surgery.

[5]  H. Takita,et al.  Regeneration of periodontal ligament and cementum by BMP-applied tissue engineering. , 1998, European journal of oral sciences.

[6]  S. Lynch,et al.  Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. , 1991, Journal of periodontology.

[7]  S. Cook,et al.  Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. , 1994, Clinical orthopaedics and related research.

[8]  Y. Ikada,et al.  Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. , 1999, Biomaterials.

[9]  Kinam Park,et al.  Biodegradable Hydrogels for Drug Delivery , 1993 .

[10]  J. Hollinger,et al.  Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). , 1994, Journal of biomedical materials research.

[11]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[12]  P. Puolakkainen,et al.  Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants. , 1994, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[13]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[14]  Wayne R. Gombotz,et al.  The Enhancement in Wound Healing by Transforming Growth Factor-β1 (TGF-β1) Depends on the Topical Delivery System , 1995 .

[15]  B. Melsen,et al.  Limited chondro‐osteogenesis by recombinant human transforming growth factor‐β1 in calvarial defects of adult baboons (papio ursinus) , 1996 .

[16]  R Langer,et al.  Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.

[17]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[18]  L. F. Fajardo,et al.  The disc angiogenesis system. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[19]  S. Shenaq,et al.  Increased Free Fat‐Graft Survival with the Long‐Term, Local Delivery of Insulin, InsulinLike Growth Factor‐I, and Basic Fibroblast Growth Factor by PLGA/PEG Microspheres , 2000, Plastic and reconstructive surgery.

[20]  Y. Tabata,et al.  Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. , 2005, Tissue engineering.

[21]  Y. Ikada,et al.  Surfactant-Free Preparation of Biodegradable Hydrogel Microspheres for Protein Release , 1999 .

[22]  Y. Tabata,et al.  Controlled Release of Hepatocyte Growth Factor from Gelatin Hydrogels Based on Hydrogel Degradation , 2001, Journal of drug targeting.

[23]  P Aebischer,et al.  Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps , 1989, Journal of neuroscience research.

[24]  Alexander M Seifalian,et al.  The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. , 2005, Biomaterials.

[25]  C. Doillon,et al.  Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo applications to collagen-based materials. , 1994, Biomaterials.

[26]  J. Heckman,et al.  The use of bone morphogenetic protein in the treatment of non-union in a canine model. , 1991, The Journal of bone and joint surgery. American volume.

[27]  Y Ikada,et al.  Controlled release of vascular endothelial growth factor by use of collagen hydrogels , 2000, Journal of biomaterials science. Polymer edition.

[28]  Y. Ikada,et al.  Growth factor release from amylopectin hydrogel based on copper coordination. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Y. Tabata,et al.  Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. , 2003, Journal of the American College of Cardiology.

[30]  T. Yoshimine,et al.  Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils , 1992, Neuroscience Letters.

[31]  E. Dawson,et al.  Beta-tricalcium phosphate delivery system for bone morphogenetic protein. , 1984, Clinical orthopaedics and related research.

[32]  D J Mooney,et al.  Release from alginate enhances the biological activity of vascular endothelial growth factor. , 1998, Journal of biomaterials science. Polymer edition.

[33]  Y. Taniyama,et al.  Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model: Molecular Mechanisms of Delayed Angiogenesis in Diabetes , 2001, Circulation.

[34]  R O Bonow,et al.  Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. , 2000, Circulation.

[35]  Y. Ikada,et al.  Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. , 2000, Biomaterials.

[36]  Y Ikada,et al.  Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. , 1999, Journal of biomaterials science. Polymer edition.

[37]  K. Takaoka,et al.  Telopeptide‐depleted bovine skin collagen as a carrier for bone morphogenetic protein , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[38]  Y. Ikada,et al.  De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. , 2000, Tissue engineering.

[39]  J M Davidson,et al.  Sustained release of epidermal growth factor accelerates wound repair. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Y. Ikada,et al.  Skull bone regeneration in primates in response to basic fibroblast growth factor. , 1999, Journal of neurosurgery.

[41]  Y. Ikada,et al.  Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. , 1998, Journal of biomaterials science. Polymer edition.

[42]  A. Linde,et al.  Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. , 1997, Journal of biomedical materials research.

[43]  T. Riss,et al.  Calcium alginate beads as a slow‐release system for delivering angiogenic molecules In Vivo and In Vitro , 1992, Journal of cellular physiology.

[44]  Takashi Inamoto,et al.  Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. , 2003, Biomaterials.

[45]  Y. Tabata,et al.  Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. , 2002, Tissue engineering.

[46]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[47]  T J Ebner,et al.  Sustained release of nerve growth factor from biodegradable polymer microspheres. , 1992, Neurosurgery.

[48]  W Grossman,et al.  Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. , 1994, The Journal of clinical investigation.

[49]  A. Feldman,et al.  Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies , 1998, Nature Medicine.

[50]  Y. Ikada,et al.  Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-β1 , 2000, Journal of biomaterials science. Polymer edition.

[51]  Y. Ikada,et al.  Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1. , 2000, Tissue engineering.

[52]  Y. M. Lee,et al.  Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. , 2000, Biomaterials.

[53]  J. Wozney,et al.  Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. , 1995, Journal of periodontology.

[54]  C. Bünger,et al.  Transforming growth factor-beta1 adsorbed to tricalciumphosphate coated implants increases peri-implant bone remodeling. , 2001, Biomaterials.

[55]  Y Ikada,et al.  Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collage scaffold ns , 2003 .

[56]  Y Ikada,et al.  Bone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability. , 2000, Journal of neurosurgery.

[57]  Y. Ikada,et al.  Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels , 1994 .

[58]  A. Reddi,et al.  Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. , 1992, Plastic and reconstructive surgery.

[59]  L. Kedes,et al.  Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. , 2000, Journal of the American College of Cardiology.

[60]  Y. Tabata,et al.  Enhanced Formation of Fibrosis in a Rabbit Aneurysm by Gelatin Hydrogel Incorporating Basic Fibroblast Growth Factor , 2001, Neurosurgery.

[61]  S. Shenaq,et al.  Augmentation of Adipofascial Flaps Using the Long-Term Local Delivery of Insulin and Insulin-Like Growth Factor-1 , 2000, Plastic and reconstructive surgery.

[62]  A. Mizoguchi,et al.  Basic Fibroblast Growth Factor Promotes Extension of Regenerating Axons of Peripheral Nerve. In Vivo Experiments Using a Schwann Cell Basal Lamina Tube Model , 1997, Journal of neurocytology.

[63]  Y. Ikada,et al.  The Efficacy of Prevascularization by Basic FGF for Hepatocyte Transplantation Using Polymer Devices in Rats , 2001, Cell transplantation.

[64]  Y. Ikada,et al.  Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[65]  A. Tencer,et al.  Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth. , 1996, Biomaterials.

[66]  E. Hay,et al.  Cell Biology of Extracellular Matrix , 1988, Springer US.

[67]  Ikada,et al.  Protein release from gelatin matrices. , 1998, Advanced drug delivery reviews.

[68]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[69]  C. Serdar,et al.  De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor. , 1994, The Journal of clinical investigation.

[70]  K. Takaoka,et al.  Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[71]  S. Goldstein,et al.  Gene therapy for tissue repair and regeneration. , 1998, Advanced drug delivery reviews.

[72]  M. Sporn,et al.  Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. , 1987, Science.

[73]  Y. Ikada,et al.  Biodegradation of hydrogel carrier incorporating fibroblast growth factor. , 1999, Tissue engineering.

[74]  G. Muschler,et al.  Evaluation of Human Bone Morphogenetic Protein 2 in a Canine Spinal Fusion Model , 1994, Clinical orthopaedics and related research.